Literature DB >> 18560898

Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.

Hong Seo Choi1, Hana Kim, Ayoung Won, Jum-Ji Kim, Chae-Yeon Son, Kyoung-Soo Kim, Jeong Heon Ko, Mi-Young Lee, Cheorl-Ho Kim, Chun Jeih Ryu.   

Abstract

Little is known about the cell-surface molecules that are related to the undifferentiated and pluripotent state of human embryonic stem cells (hESCs). Here, we generated a panel of murine monoclonal antibodies (MAb) against undifferentiated hESCs by a modification of a previously described decoy immunization strategy. H9 hESCs were differentiated in the presence of retinoic acid and used as a decoy immunogen. Twelve Balb/c mice were immunized in the right hind footpads with differentiated H9 cells and in the left hind footpads with undifferentiated H9 cells. After immunization, the left popliteal lymph node cells were collected and were fused with mouse myeloma cells. The fusion resulted in 79 hybridomas secreting MAbs that bound to the undifferentiated H9 cells as shown by flow cytometric analysis. Of these, 70 MAbs bound to the undifferentiated H9 cells, but only weakly or not at all to the differentiated H9 cells. We characterized 37 MAbs (32 IgGs, 5 IgMs) recognizing surface molecules that were down-regulated during embryoid body cell formation. One of the MAbs, L125-C2, was confirmed to immunoprecipitate CD9, previously known as a surface molecule on the undifferentiated hESCs. To investigate the relationship between the MAbs and hESC-specific antibodies, two representative MAbs, viz., L125-C2 and 291-D4, were selected and studied by multi-color flow cytometric analysis. This showed that more than 60% of L125-C2- and 291-D4-positive cells were also positive for the expression of hESC-specific surface molecules such as SSEA3, SSEA4, TRA-1-60, and TRA-1-81, indicating the close relationship between the two MAbs and the hESC-specific surface molecules. Our results suggest that the decoy immunization strategy is an efficient method for isolating a panel of MAbs against undifferentiated hESCs, and that the generated MAbs should be useful for studying the surface molecules on hESCs in the pluripotent and undifferentiated state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560898     DOI: 10.1007/s00441-008-0632-6

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  14 in total

Review 1.  The quest of cell surface markers for stem cell therapy.

Authors:  Anna Meyfour; Sara Pahlavan; Mehdi Mirzaei; Jeroen Krijgsveld; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell Mol Life Sci       Date:  2020-07-24       Impact factor: 9.261

Review 2.  Technical approaches to induce selective cell death of pluripotent stem cells.

Authors:  Ho-Chang Jeong; Seung-Ju Cho; Mi-Ok Lee; Hyuk-Jin Cha
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

3.  Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.

Authors:  Ditte C Andersen; Angela Kortesidis; Andrew C W Zannettino; Irina Kratchmarova; Li Chen; Ole N Jensen; Børge Teisner; Stan Gronthos; Charlotte H Jensen; Moustapha Kassem
Journal:  Mol Cells       Date:  2011-05-23       Impact factor: 5.034

4.  Epitope Mapping of Antibodies Suggests the Novel Membrane Topology of B-Cell Receptor Associated Protein 31 on the Cell Surface of Embryonic Stem Cells: The Novel Membrane Topology of BAP31.

Authors:  Won-Tae Kim; Hong Seo Choi; Hyo Jeong Hwang; Han-Sung Jung; Chun Jeih Ryu
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

5.  In vivo Evaluation of Human Embryonic Stem Cells Isolated by 57-C11 Monoclonal Antibody.

Authors:  Won-Tae Kim; Hyun Min Lee; Min Kyu Kim; Hong Seo Choi; Chun Jeih Ryu
Journal:  Int J Stem Cells       Date:  2016-11-30       Impact factor: 2.500

6.  Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.

Authors:  Won-Tae Kim; Saemina Shin; Hyo Jeong Hwang; Min Kyu Kim; Han-Sung Jung; Hwangseo Park; Chun Jeih Ryu
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 7.  Cancer stem cell surface markers on normal stem cells.

Authors:  Won-Tae Kim; Chun Jeih Ryu
Journal:  BMB Rep       Date:  2017-06       Impact factor: 4.778

8.  Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells.

Authors:  Se-Ri Seo; Hyun Min Lee; Hong Seo Choi; Won-Tae Kim; Eun-Wie Cho; Chun Jeih Ryu
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

9.  Progesterone Receptor Membrane Component 1 suppresses the p53 and Wnt/β-catenin pathways to promote human pluripotent stem cell self-renewal.

Authors:  Ji Yea Kim; So Young Kim; Hong Seo Choi; Min Kyu Kim; Hyun Min Lee; Young-Joo Jang; Chun Jeih Ryu
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

10.  Epitope mapping of anti-PGRMC1 antibodies reveals the non-conventional membrane topology of PGRMC1 on the cell surface.

Authors:  Ji Yea Kim; So Young Kim; Hong Seo Choi; Sungkwan An; Chun Jeih Ryu
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.